Medical International Technology Inc. "MIT" Announces that it has received a US Patent for its Needle-Free Je...( DENVER CO April 2 / Medical Internati...),Health

DENVER, CO, April 2 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH. PK) (http://www.mitcanada.ca http://www.mitinvest.ca), is pleased to announce that it has obtained another US patent from the United States Patent and Trademark Office for its Needle-Free Jet-Injector. Other similar international patents are pending. "MIT" is pleased to obtain this patent for it will help the company enter the biggest world market using a unique low-pressure Needle-free technology. This technology offers a front-line means of prevention against pandemics, contributes to eliminate the possibility of both pre-injection contamination and post-injection cross-infection from needles/syringes, increases institutional sanitation, and protects human health. This patent reinforces the validity and recognition of our technology.

This technology is the outcome of more than twenty-eight years of research and development and the driving force behind the Med-Jet(R) product line for humans and the Agro-Jet(R) product line for animals.

"MIT" is consolidating its efforts, strengthening its team, reorganizing its marketing / sales departments and financial bases in anticipation of its future growth.

Medical International Technology Inc. is pleased to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet(R) and Agro-Jet(R) Needle-Free injection system.

Karim Menassa, President

On Behalf of the Board of Directors

About Medical International Technology, Inc. MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for ind
'/>"/>